Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020112613 - HEPATIC ULTRASOUND IMPROVES METABOLIC SYNDROME, FATTY LIVER DISEASE AND INSULIN RESISTANCE AND DECREASES BODY WEIGHT

Publication Number WO/2020/112613
Publication Date 04.06.2020
International Application No. PCT/US2019/062960
International Filing Date 25.11.2019
IPC
A61K 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K 45/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
CPC
A61K 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K 45/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Applicants
  • THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH [US]/[US]
Inventors
  • HUERTA, Tomas
  • CHAVAN, Sangeeta, S.
  • TRACEY, Kevin, J.
Agents
  • MILLER, Alan, D.
  • ARNOLD, Craig, J.
  • AMOS, Brian, J.
Priority Data
62/771,94327.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) HEPATIC ULTRASOUND IMPROVES METABOLIC SYNDROME, FATTY LIVER DISEASE AND INSULIN RESISTANCE AND DECREASES BODY WEIGHT
(FR) ULTRASONS HÉPATIQUES UTILISÉS POUR TRAITER LE SYNDROME MÉTABOLIQUE, LA STÉATOSE HÉPATIQUE ET L'INSULINORÉSISTANCE ET DIMINUER LE POIDS CORPOREL
Abstract
(EN)
Methods are disclosed for treating a subject with metabolic syndrome, fatty liver disease, insulin resistance, inflammation or elevated body weight using hepatic ultrasound.
(FR)
L'invention concerne des méthodes de traitement d'un sujet atteint d'un syndrome métabolique, d'une stéatose hépatique, d'une insulinorésistance, d'une inflammation ou d'un poids corporel élevé à l'aide d'ultrasons hépatiques.
Latest bibliographic data on file with the International Bureau